Adagio Medical Holdings, Inc.
ADGM · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.01 | 0.00 | -1.40 | -0.00 |
| FCF Yield | -102.51% | -36.56% | -0.57% | -1.35% |
| EV / EBITDA | -0.19 | -4.00 | -7.60 | -8.83 |
| Quality | ||||
| ROIC | -153.03% | 1,301.44% | -18.71% | -4.58% |
| Gross Margin | -620.07% | -335.33% | -362.96% | -328.89% |
| Cash Conversion Ratio | 0.39 | 0.70 | 0.95 | 0.97 |
| Growth | ||||
| Revenue 3-Year CAGR | 12.49% | 3.57% | – | 646,230.41% |
| Free Cash Flow Growth | 37.07% | -2,532.92% | 57.85% | 0.00% |
| Safety | ||||
| Net Debt / EBITDA | 0.07 | -1.41 | -0.18 | 0.03 |
| Interest Coverage | 56.70 | -16.84 | -7.37 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.75 | 0.39 | 2.38 | 3.47 |
| Cash Conversion Cycle | -4.14 | -55.59 | -268.64 | -32.30 |